2 hours ago
Rocket Pharmaceuticals (RCKT) Stock Surges After FDA Approves Groundbreaking Gene Therapy
Rocket Pharmaceuticals (RCKT) stock surged 9% after FDA approved KRESLADI, the first gene therapy for severe LAD-I in children. Details on approval inside.
The post Rocket Pharmaceuticals (RCKT) Stock Surges After FDA Approves Groundbreaking Gene Therapy appeared first on Blockonomi.
Source: Blockonomi →Related News
- 2 hours ago
Lumentum (LITE) Stock Plunges 11%, Then Rebounds on NVIDIA Partnership Announcem...
- 2 hours ago
ChatGPT Ad Program Generates $100M Annualized Revenue Within Six Weeks
- 2 hours ago
Super Micro Computer (SMCI) Stock Plunges Amid Reports of PLA-Affiliated Univers...
- 2 hours ago
Unity Software (U) Shares Soar 15% as Q1 Preliminary Earnings Crush Expectations
- 2 hours ago
Wayfair (W) Stock Drops 7.6% Following Insider Sales Totaling $1.6 Million